Skip to main content
. Author manuscript; available in PMC: 2013 Apr 9.
Published in final edited form as: Lab Invest. 2009 Jun 1;89(8):903–914. doi: 10.1038/labinvest.2009.51

Figure 5.

Figure 5

Impaired TGFβ1/Smad Signaling in SRC-3−/− mice. (a) Western blot analysis of TGFβ1, phospho-Smad2 (p-SMAD2), total Smad2 (t-SMAD2), phospho-Smad3 (p-SMAD3) and total Smad3 (t-SMAD3) expression levels in livers from SRC-3+/+ and SRC-3−/− mice treated chronically with CCl4 for 3 weeks. GAPDH was used as an invariant control. (b) Western blot analysis of Cyclin D1 and BAX expression levels in livers from SRC-3+/+ and SRC-3−/− mice treated chronically with CCl4 for 3 weeks. GAPDH was used as an invariant control.